CUA Educational Content

Insights on Early Stage RCC Detection & Emerging Management Strategies

EDITORIAL COMMITTEE: ALY-KHAN LALANI, ANIL KAPOOR, DANIEL HENG, RICARDO RENDON

LEARNING OBJECTIVES:

At the conclusion of this program, participants should be able to:

  • Recognize early RCC disease stage symptoms and underlying risk factors associated with recurrence rates
  • Assess emergent adjuvant RCC clinical trial data and their impact on current clinical practice
  • Identify key patient factors important for the consideration of adjuvant therapy in early stage RCC

 

button

*Please contact tal.erdman@cua.org to request the powerpoint slides. 

 


​This program was made possible with financial support from Merck.